Xeris Granted Fast Track Designation by the FDA for Its Novel Concentrated Diazepam Formulation (XP-0863) For Injection Read more
NGM Expands Oncology Portfolio with First Immuno-Oncology Development Candidate, NGM707, a Novel Dual Antagonist Antibody Inhibiting ILT2 and ILT4 Read more
Akron Biotech Signs Agreement With Synairgen plc to Supply Interferon-beta for COVID-19 Treatment Read more
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech Read more
Dr. Reddy’s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India Read more
Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) Read more